Prerequisites for the natriuretic effect of val-5-angiotensin II amide in the rat.
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D003681:Dehydration; D004231:Diuresis / Q000187:drug effects; D005110:Extracellular Space; D005919:Glomerular Filtration Rate; D006852:Hydrochlorothiazide / Q000494:pharmacology; D007038:Hypotonic Solutions; D007263:Infusions, Parenteral; D007444:Inulin / Q000378:metabolism; D007552:Isotonic Solutions; D007668:Kidney / Q000187:drug effects*; D007677:Kidney Function Tests; D007684:Kidney Tubules / Q000502:physiology; D008297:Male; D009318:Natriuresis / Q000187:drug effects*; D009994:Osmolar Concentration; D051381:Rats; D012964:Sodium / Q000378:metabolism; D014867:Water / Q000378:metabolism; D014882:Water-Electrolyte Balance
D007038:Hypotonic Solutions; D007552:Isotonic Solutions; D014867:Water; D006852:Hydrochlorothiazide; D000804:Angiotensin II; D007444:Inulin; D012964:Sodium